Pfizer’s 2025 lipid nanoparticle (LNP) production for mRNA therapies sources 80% of its lecithin from Cargill’s genetically optimized soy strains, which enhance drug encapsulation efficiency ...

Pfizer’s 2025 lipid nanoparticle (LNP) production for mRNA therapies sources 80% of its lecithin from Cargill’s genetically optimized soy strains, which enhance drug encapsulation efficiency by 30%.

Pfizer's 2025 lipid nanoparticle (LNP) production for mRNA therapies sources 80% of its lecithin from Cargill's genetically optimized soy strains, which enhance drug encapsulation efficiency by 30%.

Introduction De-oiled lecithin is a highly concentrated form of lecithin that has had its oil content removed, resulting in a powdered or granu ...

Safeway, Albertsons, Vons, Trader Joe's, and Aldi stock enormous volumes of "organic" and "natural" foods from countries like ...

The optimism expressed by Sousa reflects a record 2025 soybean harvest and beneficial weather for Brazil's second corn crop, ...

SAO PAULO, April 4 (Reuters) - Indigenous protests and poor roads have disrupted shipping of Brazil's bumper soybean crop in ... global companies including Cargill and Bunge (BG.N), opens new ...